CORRECTION article

Front. Endocrinol., 19 December 2024

Sec. Pediatric Endocrinology

Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1461564

Corrigendum: The role of oxidized lipid species in insulin resistance and NASH in children

  • 1. Department of Pediatrics, Kansas Medical Center, Kansas City, KS, United States

  • 2. Department of Medicine and Health Sciences, “V.Tiberio” University of Molise, Campobasso, Italy

  • 3. Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States

  • 4. Department of Pediatrics, University of California San Diego, La Jolla, CA, United States

  • 5. Global Drug Discovery, Novo Nordisk, Copenhagen, Denmark

In the published article, there was an error regarding the affiliations for Ariel E. Feldstein. As well as having affiliation 4, they should also have “Global Drug Discovery, Novo Nordisk, Copenhagen, Denmark”.

In the published article, there was an error in the Conflicts of interest, and a declaration regarding author Ariel E. Feldstein was erroneously excluded.

The corrected Conflicts of interest section appears below.

“AF is an employee and stockholder of Novo Nordisk.

The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The author apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

lipids, PUFA (polyunsaturated fatty acids), NAFLD (nonalcoholic fatty liver disease), diabetes, children

Citation

Santoro N and Feldstein AE (2024) Corrigendum: The role of oxidized lipid species in insulin resistance and NASH in children. Front. Endocrinol. 15:1461564. doi: 10.3389/fendo.2024.1461564

Received

08 July 2024

Accepted

10 July 2024

Published

19 December 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Ariel E. Feldstein,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics